NQO1 and COVID-19: Having revealed the expression profile of DCM’s targets (NQO1 and VKORC1) in AECs, we then explored whether the NQO1 and VKORC1 expressions in AECs correlated with the COVID-19 severity in clinical patients (Fig. 4a).